pfizer glp 1 news scraps daily weight loss pill danuglipron after a liver injury China Opens Its Weight-Loss Drug

While some individuals see weight loss results on these medications without changing the types of foods they eat, this isn't ideal nor the healthiest way to go about it

At present, the small molecules segment holds the maximum share of the GLP-1 market

These may signal that your current dose, formulation, or medication choice isn't the right fit, and adjustments or alternatives exist to help you tolerate treatment comfortably

Therefore, DMSO control with 1.3% ( 640 M atpenin) was added to exclude false positive cell toxicity

doi: 10.3389/fphar.2026.1798309 Received 28 January 2026 Revised 27 February 2026 Accepted 28 February 2026 Published 26 March 2026 Volume 17 - 2026 Edited by Marcos Roberto De Oliveira, Federal University of Rio Grande do Sul, Brazil Reviewed by Maria Jos De Rosa, CONICET Baha Blanca, Argentina Shubham Teli, BVVS Hanagal Shri Kumareshwar College of Pharmacy, India Updates Copyright 2026 Juthi, Ansari, Ahmed, Khan, Seidel, Kumar, Kumari, McKillop, Abdel-Wahab and Flatt